Profile
Patrick Yue is Chief Medical Officer at Sirius Therapeutics since 2024.
Formerly, Dr. Yue was Senior Vice President-Clinical Development at Centessa Pharmaceuticals Plc from 2023 to 2024, Executive Director-Clinical Science at Global Blood Therapeutics, Inc. from 2020 to 2023, and Executive Director-Clinical Development at Portola Pharmaceuticals LLC from 2016 to 2020.
Education includes an undergraduate degree from California Institute of Technology in 1995 and a doctorate from Washington University School of Medicine in 1999.
Patrick Yue active positions
| Companies | Position | Start |
|---|
Former positions of Patrick Yue
| Companies | Position | End |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Corporate Officer/Principal | 01/06/2024 |
| GLOBAL BLOOD THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/02/2023 |
| PORTOLA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/10/2020 |
Training of Patrick Yue
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Washington University School of Medicine
Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centessa Pharmaceuticals Plc
Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders | Health Technology |
- Stock Market
- Insiders
- Patrick Yue
















